BeStock  
Stocks › Biotechnology › NKTR

Nektar Therapeutics NKTR

US equityMarket cap rank #3135Biotechnology
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$137.75+356.1% vs. price
  • Buy 70%
  • Hold 30%
Low $40.00Now $30.20Avg $137.75High $192.00

Recent rating changes

The last 20 actions on file set price targets from $40.00 to $192.00, averaging $151.06.

DateFirmRatingTarget
13 Nov 2026 Piper Sandler BUY $192.00
13 Nov 2026 Wedbush HOLD $40.00
22 Oct 2026 Piper Sandler BUY $192.00
12 Oct 2026 UBS HOLD $53.00
12 Oct 2026 Leerink Partners BUY $130.00
11 Oct 2026 UBS HOLD $53.00
9 Oct 2026 BTIG BUY $178.00
8 Oct 2026 Raymond James HOLD –
5 Oct 2026 Citi BUY $151.00
2 Oct 2026 H.C. Wainwright BUY $185.00
1 Oct 2026 William Blair BUY –
1 Oct 2026 Jefferies BUY $150.00
1 Oct 2026 H.C. Wainwright BUY $185.00
29 Sep 2026 BTIG BUY $178.00
28 Sep 2026 CCORF BUY $153.00
25 Sep 2026 BTIG BUY $178.00
17 Sep 2026 BTIG BUY $178.00
16 Sep 2026 BTIG BUY $178.00
20 Aug 2026 Piper Sandler BUY $192.00
17 Aug 2026 CCORF BUY $153.00

Discussion

No comments yet — be the first to weigh in on NKTR.

Sign in to join the discussion.

Scroll to Top